THE PROGNOSTIC VALUE OF ANTI CITRULLINATED PROTEIN ANTIBODY TEST IN RHEUMATOID ARTHRITIS

The Association Between Anti-Cyclic Citrullinated Peptide and Anti-Mutated Citrullinated Vimentin and The Extra-articular Manifestations in Patients with Rheumatoid Arthritis

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES VERSUS ANTI-MUTATED CITRULLINATED VIMENTIN ANTIBODIES IN JUVENILE IDIOPATHIC ARTHRITIS

Anti-carbamylated protein antibodies in rheumatoid arthritis

Bone Mineral Density in Female Patients with Rheumatoid Arthritis in Relation to Anti-Cyclic Citrullinated Peptide Antibody and Rheumatoid Factor

Serum Peptidyl Argenine Deiminase - 4 (PADI4) Antibodies in Rheumatoid Arthritis and their Correlation with Disease Activity

Study of Peptidyl Arginine Deiminases 4 (PAD 4) Antibodies in Rheumatoid Arthritis Patients

Study of the relationship between anti-citrullinated protein antibodies and occurrence of interstitial lung disease in patients with rheumatoid arthritis

ASSESSMENT OF 14-3-3 PROTEIN ETA AND ANTI-CYCLIC CITRULLINATED PEPTIDE (ANTI-CCP) IN JUVENILE IDIOPATHIC ARTHRITIS VERSUS ADULT ONSET RHEUMATOID ARTHRITIS

Anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis patients : Relation to disease activity and manifestations